These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10969232)

  • 21. Tenecteplase for acute ischemic stroke.
    Lyden P
    Int J Stroke; 2011 Dec; 6(6):509-10. PubMed ID: 22111795
    [No Abstract]   [Full Text] [Related]  

  • 22. Tissue plasminogen activator use in a patient with acute ischemic stroke coexisting with meningioma.
    Hsieh HC; Chen CH
    Clin Neurol Neurosurg; 2009 Jul; 111(6):562-3. PubMed ID: 19200644
    [No Abstract]   [Full Text] [Related]  

  • 23. Letter by Chao et al regarding article, "standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses".
    Chao AC; Po HL; Chan L
    Stroke; 2014 Dec; 45(12):e303. PubMed ID: 25342029
    [No Abstract]   [Full Text] [Related]  

  • 24. Letter by Behrouz et Al regarding article, "Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion".
    Behrouz R; Mutgi SA; Silver B
    Stroke; 2015 Jun; 46(6):e149. PubMed ID: 25899241
    [No Abstract]   [Full Text] [Related]  

  • 25. Patient management problem.
    Kelly AG
    Continuum (Minneap Minn); 2014 Apr; 20(2 Cerebrovascular Disease):476-81, 482-93. PubMed ID: 24699498
    [No Abstract]   [Full Text] [Related]  

  • 26. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score.
    Bruno A; Switzer JA
    Neurology; 2012 Jul; 79(5):486-7; author reply 486-7. PubMed ID: 22851721
    [No Abstract]   [Full Text] [Related]  

  • 27. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score.
    Kent TA
    Neurology; 2012 Apr; 78(17):1368. PubMed ID: 22529207
    [No Abstract]   [Full Text] [Related]  

  • 28. Right brain: my first tPA.
    Robbins MS
    Neurology; 2009 Jul; 73(2):e9-e10. PubMed ID: 19597130
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of acute ischemic apoplexy].
    Andersen G; Krieger DW; Iversen HK
    Ugeskr Laeger; 2009 Mar; 171(13):1094. PubMed ID: 19321089
    [No Abstract]   [Full Text] [Related]  

  • 30. Door-to-needle times in acute ischemic stroke: how low can we go?
    Smith EE; von Kummer R
    Neurology; 2012 Jul; 79(4):296-7. PubMed ID: 22622861
    [No Abstract]   [Full Text] [Related]  

  • 31. Breaking up is hard to do: tenecteplase in acute stroke.
    Schwamm LH
    Lancet Neurol; 2015 Apr; 14(4):343-5. PubMed ID: 25726503
    [No Abstract]   [Full Text] [Related]  

  • 32. [Thrombolytic therapy in stroke approved with reservation. Underlying evidence, practical guidelines and safety follow up].
    Wahlgren NG
    Lakartidningen; 2004 Feb; 101(8):674-7. PubMed ID: 15024940
    [No Abstract]   [Full Text] [Related]  

  • 33. rt-PA for ischaemic stroke: what will the next question be?
    Leys D; Cordonnier C
    Lancet; 2012 Jun; 379(9834):2320-1. PubMed ID: 22632906
    [No Abstract]   [Full Text] [Related]  

  • 34. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.
    Schestatsky P; Picon PD
    Neurology; 2005 Dec; 65(11):1844; author reply 1844. PubMed ID: 16344546
    [No Abstract]   [Full Text] [Related]  

  • 35. Switched On-Expert Advice in Prehospital Thrombolysis via Telemedicine.
    Ebinger M; Audebert HJ
    JAMA Neurol; 2016 Feb; 73(2):153-4. PubMed ID: 26642263
    [No Abstract]   [Full Text] [Related]  

  • 36. UK drug agency announces review of use of alteplase after stroke.
    Cohen D; Macdonald H
    BMJ; 2014 Sep; 349():g5355. PubMed ID: 25179758
    [No Abstract]   [Full Text] [Related]  

  • 37. rtPA in acute stroke patients with history of cognitive impairment: do not hesitate to treat.
    Román GC; Hakim AM
    Neurology; 2014 Jun; 82(23):2044-5. PubMed ID: 24827496
    [No Abstract]   [Full Text] [Related]  

  • 38. When is enough enough?
    Donnan GA; Davis SM
    Stroke; 2001 Nov; 32(11):2710-1. PubMed ID: 11692042
    [No Abstract]   [Full Text] [Related]  

  • 39. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.
    Kleindorfer DO; Khatri P; Katzan I
    Neurology; 2005 Dec; 65(11):1844; author reply 1844. PubMed ID: 16353320
    [No Abstract]   [Full Text] [Related]  

  • 40. Breaking the 3 h barrier for treatment of acute ischaemic stroke.
    Donnan GA; Davis SM
    Lancet Neurol; 2008 Nov; 7(11):981-2. PubMed ID: 18940690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.